(NASDAQ: ELTX) Elicio Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.
Elicio Therapeutics's earnings in 2025 is -$51,280,000.On average, 1 Wall Street analyst forecast ELTX's earnings for 2025 to be -$41,272,198, with the lowest ELTX earnings forecast at -$41,272,198, and the highest ELTX earnings forecast at -$41,272,198.
In 2026, ELTX is forecast to generate -$42,551,956 in earnings, with the lowest earnings forecast at -$42,551,956 and the highest earnings forecast at -$42,551,956.